Assessment of Elemental Impurities Level After Multiple Administration of DWJ1230 or DWB2001 in Subjects With Functional Diarrhea or Irritable Bowel Syndrome With Predominant Diarrhea.

NCT05816681 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Diarrhea

Interventions

DRUG: DWJ1230
DRUG: DWB2001

Sponsor

Daewoong Pharmaceutical Co. LTD.